RASGRF2 and breast carcinoma: A similar analysis for relapse free survival (RFS) of basal-like breast cancer patients using the KM plotter software for breast cancer [27] revealed that the expression level of GRF2 in basal-like breast tumors is significantly associated with relapse free survival (logrank P = 0.00098), while that of SOS1 is not.